ICM
GH icon

Islay Capital Management’s Guardant Health GH Stock Holding History

Islay Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10
Closed -$520 – 220
2025
Q2 		$520 Buy
+10
New +$447 ﹤0.01% 190

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Islay Capital Management's GH Position: Q3 2025 in Review

Islay Capital Management sold out of Guardant Health (GH) in Q3 2025, closing a stake of 10 shares — an estimated $520 sold.

Islay Capital Management first reported a position in GH in Q2 2025 and held it in 1 quarter. The position peaked at $520 in Q2 2025. 394 funds tracked by Wall St. Rank hold GH as of Q3 2025.

  • Islay Capital Management reported no remaining Guardant Health position as of Q3 2025 after selling out during the quarter.
  • Islay Capital Management sold 10 Guardant Health shares in Q3 2025, an estimated $520.
  • Islay Capital Management first reported a position in Guardant Health in Q2 2025 and held it in 1 quarter.
  • Islay Capital Management's Guardant Health position peaked at $520 in Q2 2025.
  • 394 funds tracked by Wall St. Rank held Guardant Health as of Q3 2025.

Based on Islay Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.